157: A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiotherapy (SABR) Plus Surgery in Operable Patients with Early Non-Small Cell Lung Cancer (Missile-NSCLC): Interim Safety Results. (September 2016) - Palma, David; Kwan, Keith; Gaede, Stewart; Landis, Mark; Malthaner, Richard; Fortin, Dalilah; Louie, Alexander; Frechette, Eric; Rodrigues, George; Yaremko, Brian; Yu, Edward; Dar, Rashid; et al.